Vivo Capital’s BlossomHill Therapeutics BLSM Stock Holding History
Bought
Maintained
Sold
Other funds holding BLSM
Vivo Capital's BLSM Position: Q3 2026 in Review
Vivo Capital opened a new position in BlossomHill Therapeutics (BLSM) in Q3 2026: 1,493,740 shares worth $27.8M. The stake represents 3.06% of the portfolio and ranks #13 among its holdings.
39 funds tracked by Wall St. Rank hold BLSM as of Q3 2026.
- Vivo Capital held 1,493,740 shares of BlossomHill Therapeutics worth $27.8M as of Q3 2026.
- BlossomHill Therapeutics was a new Vivo Capital position in Q3 2026.
- BlossomHill Therapeutics made up 3.06% of Vivo Capital's portfolio in Q3 2026, its #13 holding.
- 39 funds tracked by Wall St. Rank held BlossomHill Therapeutics as of Q3 2026.
Based on Vivo Capital's 13F filing for Q3 2026, filed 13 Nov 2026.